Results 181 to 190 of about 1,574,238 (214)

Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF₁ receptor heterotetramer. [PDF]

Pharmacol Res
Sanchez WN, Moreno E, Ciruela-Jardí M, Casajuana-Martín N, Yauch A, Cai NS, Quiroz C, Chang YG, Casadó V, Pardo L, Plant LD, Ferré S.   +11 more
europepmc   +1 more source

Ketamine Evokes Acute Behavioral Effects Via μ Opioid Receptor-Expressing Neurons of the Central Amygdala. [PDF]

Biol Psychiatry
Pomrenze MB, Vaillancourt S, Llorach P, Rijsketic DR, Casey AB, Gregory N, Zhao W, Girard TE, Mattox KT, Salgado JS, Malenka RC, Heifets BD.   +11 more
europepmc   +1 more source

Neuronal Colocalization of μ-Opioid Receptor, κ-Opioid Receptor, and Oxytocin Receptor mRNA in the Central Nucleus of the Amygdala in Male and Female Mice. [PDF]

eNeuro
Nisbett KE, Koob GF.
europepmc   +1 more source

Impact of Intracellular Proteins on μ-Opioid Receptor Structure and Ligand Binding. [PDF]

J Phys Chem B
Scott CE, Juechter LA, Rocha J, Jones LD, Outten B, Aishman TD, Ivers AR, Shields GC.   +7 more
europepmc   +1 more source

Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid Receptor. [PDF]

J Chem Inf Model
Cooper DA, DePaolo-Boisvert J, Nicholson SA, Gad B, Minh DDL.   +4 more
europepmc   +1 more source

Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR8554, a biased µ-opioid receptor agonist: a phase I trial in healthy volunteers. [PDF]

BMC Pharmacol Toxicol
Zhang L, Luo G, Wang H, Lou H, Yan M.
europepmc   +1 more source

Structural basis of μ-opioid receptor targeting by a nanobody antagonist. [PDF]

Nat Commun
Yu J, Kumar A, Kumar A, Zhang X, Martin C, Van Holsbeeck K, Raia P, Koehl A, Laeremans T, Steyaert J, Manglik A, Ballet S, Boland A, Stoeber M.   +13 more
europepmc   +1 more source

Exploring marine-derived bacterial compounds targeting the μ-opioid receptor agonists through metabolic profiling to molecular modeling. [PDF]

Sci Rep
Boudrahem D, Messaoudi O, Balit S, Kecha M, Wink J, Patel CN.   +5 more
europepmc   +1 more source

Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference. [PDF]

Neuropsychopharmacol Rep
Ide S, Iwase N, Arai K, Kojima M, Ushiyama S, Ikeda K.   +5 more
europepmc   +1 more source

Mapping partial agonism of mitragynine at the µ-opioid receptor through molecular dynamics and Markov state modelling analysis. [PDF]

Sci Rep
Bahari MNA, Azmi L, Fei LC, Syahir A, Perimal E, Manaf AA, Jamali MAM.   +6 more
europepmc   +1 more source